2.0
5. Aug. 2009
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
working at a company that does make a difference to the patients and their families lives makes going to work worthwhile, enabling them to live longer if just by a few months make a qorld of difference.
Kontras
the Roche comglomerate is making changes to the company that will be detrimentral in the long run both the company and eventually the patients. the 'brain drain' has become significant enough that the future pipeline is jepordized